Elisabeth Walsby
Cardiff Experimental Cancer Medicine Centre
Department of Haematology
School of Medicine
Cardiff University
UK
Name/email consistency: high
- The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Walsby, E.J., Coles, S.J., Knapper, S., Burnett, A.K. Haematologica (2011)
- The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine. Walsby, E., Lazenby, M., Pepper, C., Burnett, A.K. Leukemia (2011)
- Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts. Walsby, E., Walsh, V., Pepper, C., Burnett, A., Mills, K. Haematologica (2008)









